Laurus Labs: June ’22 Results Update
Moneylife Digital Team 08 August 2022
Laurus Labs’ (Laurus) Q1FY22-23 results instilled confidence in investors regarding its target of achieving US$1bn (billion) in sales in FY22-23. It delivered a revenue growth of 20% y-o-y (year-on-year) to Rs1,539 crore, driven by stellar growth in custom synthesis division. API (active pharmaceutical ingredient) segment recorded a moderate growth of 6% y-o-y, backed by a strong growth in the...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Get access to complete archives
Rs 5000 + GST
Already a subscriber ? Log in
Free Helpline
Legal Credit